Target type: molecularfunction
Catalysis of the reaction: S-adenosyl-L-methionine + CpG (in DNA) = S-adenosyl-L-homocysteine + 5-MeCpG (in DNA). [EC:2.1.1.37, PMID:15689527]
DNA (cytosine-5-)-methyltransferases (DNMTs) are a family of enzymes that catalyze the transfer of a methyl group from a donor molecule, typically S-adenosyl methionine (SAM), to the 5' position of cytosine bases in DNA. This process, known as DNA methylation, is a crucial epigenetic modification that plays a vital role in regulating gene expression, genomic imprinting, and maintaining genomic stability. DNMTs exhibit specificity for CpG dinucleotides, which are cytosine bases followed by a guanine base. This specificity arises from the enzyme's structure, which contains a conserved catalytic domain that interacts with both the cytosine base and the adjacent guanine base. The catalytic mechanism of DNMTs involves a series of steps, including: 1) Binding of SAM to the enzyme, 2) Recognition and binding of the CpG dinucleotide within the DNA substrate, 3) Transfer of the methyl group from SAM to the 5' position of cytosine, 4) Release of the methylated DNA and S-adenosyl homocysteine (SAH) byproduct. DNMTs are essential for development and cellular function. In mammals, there are three main DNMTs: DNMT1, DNMT3A, and DNMT3B. DNMT1 is considered a "maintenance" methyltransferase, as it primarily copies existing methylation patterns to newly synthesized DNA strands during replication. DNMT3A and DNMT3B establish de novo methylation patterns during development and play a role in regulating gene expression. Dysregulation of DNMT activity has been implicated in various diseases, including cancer, autoimmune disorders, and developmental disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
DNA (cytosine-5)-methyltransferase 3B | A DNA (cytosine-5)-methyltransferase 3B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBC3] | Homo sapiens (human) |
DNA (cytosine-5)-methyltransferase 3-like | A DNA (cytosine-5)-methyltransferase 3-like that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UJW3] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
procainamide | procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias. Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
dichlone | dichlone: structure | ||
5,5'-methylenedisalicylic acid | 5,5'-methylenedisalicylic acid: inhibits attachment of ribosomes to microsomal membranes; RN given refers to parent cpd; structure in first source & Merck Index, 9th ed, #5934 | ||
s-tubercidinylhomocysteine | |||
s-adenosyl-3-thiopropylamine | S-adenosyl-3-thiopropylamine : A thioadenosine that is adenosine in which the hydroxy group at C-5' is replaced by a 3-aminopropyl group. S-adenosyl-3-thiopropylamine: decarboxylated S-adenosylhomocysteine; RN given refers to parent cpd | organic sulfide; primary amino compound; thioadenosine | |
s-adenosylhomocysteine | S-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine. S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions. | adenosines; amino acid zwitterion; homocysteine derivative; homocysteines; organic sulfide | cofactor; EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor; EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor; epitope; fundamental metabolite |
nanaomycin a | nanaomycin A : A pyranonaphthoquinone antibiotic from strain OS-3966 of Streptomyces rosa var. notoensis. nanaomycin A: produced by a strain OS-3966 of Streptomyces rosa var. notoensis; quinone-related cpd; MF C16-H14-O6; see also nanaomycin B: 52934-85-7, nanaomycin C: 58286-55-8, nanaomycin E: 72660-52-7; structure | benzoisochromanequinone; monocarboxylic acid; organooxygen heterocyclic antibiotic; p-quinones | bacterial metabolite |
rg108 | RG108: DNA methyltransferase inhibitor; structure in first source | indolyl carboxylic acid | |
genistein | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor | |
sgi-1027 | SGI-1027: inhibits DNA methyltransferase 1; structure in first source |